BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-4375 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-4375\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07298772-11110@assetmemo.bio
DTSTAMP:20261121T004546Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:SHR-4375: Phase 1/2 readout est. (NCT07298772)
DESCRIPTION:SHR-4375\, phase 1/2\, Advanced Solid Tumors.\nStudy: A Study o
 f SHR-4375 Injection in Combination With Other Antitumor Therapies in Pati
 ents With Solid Tumors\nEstimated primary completion: January 2027. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/shr-4375#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07298772
URL:https://assetmemo.bio/drug/shr-4375#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06764628-11110@assetmemo.bio
DTSTAMP:20261121T004546Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:SHR-4375: Phase 1/2 readout est. (NCT06764628)
DESCRIPTION:SHR-4375\, phase 1/2.\nStudy: A Study of SHR-4375 in Subjects W
 ith Solid Tumors\nEstimated primary completion: May 2027. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/shr-4375#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT06764628
URL:https://assetmemo.bio/drug/shr-4375#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
